Know Before You Buy: Doing Your Due Diligence When Investing In a US Cannabis Company
Investment and mergers and acquisitions activity in the Canadian and U.S. cannabis industries has been heating up. Reverse takeovers between U.S. and Canadian cannabis companies are all the rage. All indications show that the number of deals will only increase, but investors still need to proceed with caution before signing on the dotted line. Hasty cannabis investments and consolidations can lead to serious risk and liability for investors.
Attorneys Karen Balderama and Rob Selna have represented investors and target companies in financing and M&A transactions, including conducting thorough due diligence of U.S.-based cannabis companies on behalf of U.S. and Canadian investors. Their presentation will discuss the due diligence process and the key areas that investors need to examine before investing in or acquiring a U.S. cannabis company. Attendees will learn to identify important issues that must be considered and how to best address them. Understanding the pitfalls and learning how to tackle or avoid them is crucial to establishing a successful partnership between investors and acquirers and their target cannabis companies.
BROUGHT TO YOU BY: WENDEL ROSEN BLACK & DEAN LLP